In-network therapist marketplace — finds, books, and bills insurance for patients
Headway is the largest in-network therapy marketplace in the U.S. — solving the chronic problem that ~70% of therapists don't accept insurance by handling credentialing, claims, and billing for them. Patients search, book, and pay with their insurance; therapists keep clinical autonomy and offload back-office work. Founded in 2019 by Andrew Adams (CEO), Jake Sussman, Brad Lash, and Robert Saliba, Headway raised a $100M Series D in July 2024 at a $2.3B valuation led by Spark Capital — a 130% step-up from its October 2023 Series C. Total funding: ~$326M. The Series D funds a Medicare Advantage launch across 51 markets and a 2025 Medicaid expansion that opens access to 100M+ publicly-insured Americans.
Healthcare📍 New York, NYFounded 2019
Current Valuation
$2.3B
as of 2024-Q3
UNICORN
QL Price
$1.6B
-30% vs last round
QuantLogix's current estimate for Headway, published 2026-08-29 — below the last disclosed round of $2.3B (2024-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$2.3B
2024-Q3
weight 0.27
Secondary market print
$1.3B
2026-06-27
weight 0.68
How this price has held up
No round has priced for Headway since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-08-29 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Headway, 2026-08-29 (f0d1ce38a2e24275).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Headway going public?
No. Headway is private and has not filed to go public. There is no S-1 on file.
What is Headway's valuation in 2026?
Headway is valued at $2.3B as of 2024-Q3, set by its Series D ($100M, Jul 2024). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Headway filed an S-1?
No public S-1 is on file for Headway.
Who are Headway's investors?
Headway's investors include Spark Capital, Andreessen Horowitz, Accel, GV (Google Ventures), Thrive Capital, Forerunner Ventures and 1 more.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Andrew Adams
Founded
2019
HQ
New York, NY
Employees
~800
Total Raised
$326M
Growth
130% valuation step-up at Series D (Oct 2023 $1B → Jul 2024 $2.3B); 51-market Medicare Advantage launch
Last Round
Series D — $100M (Jul 2024) · Lead: Spark Capital
IPO Status
private
Fundraising Status
Series D · $100M · 2y 1mo ago
privateTotal raised $326M
Secondary Market
Implied price / share
$6.95
Last round price / share
$12.01
vs last round
-42.1%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$100M
Jul 2024
Spark Capital
—
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
82
via ashby
Product-build share
59%
engineering, research, product, design
Trajectory
steady
product-led hiring — 59% of open roles build product; the rest are go-to-market and G&A.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Staff IT Engineer Senior Product Designer, Provider AcquisitionStaff Product Designer, Provider CRM & Prospect ManagementStaff Data Infrastructure EngineerRemote Licensed Mental Health TherapistRemote Licensed Psychiatric Nurse Practitioner
Counted from Headway's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Andrew AdamsJake SussmanBrad LashRobert Saliba
Investors
Spark Capital · Andreessen Horowitz · Accel · GV (Google Ventures) · Thrive Capital · Forerunner Ventures · Health Care Service Corporation
Products
Headway therapist marketplace
Headway Insurance Network (in-network billing for therapists)
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.